Adaptive Phage Therapeutics

Adaptive Phage Therapeutics | 1,835 followers on LinkedIn. To save lives or restore health as a leader in safe, rapidly deployable, cost-effective cures for bacterial infections | Adaptive Phage Therapeutics (APT) is a clinical-stage company advancing therapies addressing multi-drug resistant infections. Prior antimicrobial therapeutic approaches have been “fixed,” while pathogens continue to evolve resistance to each of those therapeutics, causing those drug products to become rapidly less effective in commercial use as antimicrobial resistance (AMR) increases over time. APT’s PhageBank™ approach leverages an ever-expanding library of bacteriophage (phage) that collectively provide evergreen broad spectrum and polymicrobial coverage.